Company will be presenting updating on the NDA at the Jefferies Conference in early June. IR has indicated that they got hung up in the FDA minutia. $275 mil Pfizer milestone payment is anticipated for mid- to late- 2016. This was represented by IR as well.
This thing should move considerably when the new drug app is filed over the next week. The app will get a fair amount of analyst and industry attention. OPK mgt has indicated that it will be filed this quarter.
Just a guess, but could the release be going out Friday due to a deadline for an SEC material agreement filing requirement? Or it could be that they will be finalizing a deal over the weekend and will announce it on Monday? I can't imaging they would put out a bad earnings release Friday afternoon and let everyone get worked up over the weekend only to face a hostile group Monday morning. Remember also that Frost was buying long after the quarter ended. If it were bad news he would wait for it to come out and back up the truck at lower prices.
To all my short friends (5'2" and under), cover before the presentation today. That'll be phase one. Earnings next week will be phase two. Looking for $17-19 over the next week, but that's only if now big news is out from the company or analyst. If that happens, could go a lot higher.
I'd have to agree. Weak stock action today and they have disappointed each quarter for the past couple of years. Several quarters back they even had to delay their earnings for days after the announced earnings release. That was a disaster as the stock dropped 40 percent or so. These guys seem to win a lot of business, but margins shrink, and they generally can't execute. Hopefully they'll get it together one of these quarters. Not betting on this quarter.